Journal of Cancer Research and Therapeutics

Papers
(The H4-Index of Journal of Cancer Research and Therapeutics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Factors that contribute to the recurrence of mucinous ovarian cancer: Monocenter retrospective evaluation41
Spectrum of pediatric kidney tumours with special references to WT1 immunostain at a tertiary care hospital39
Post hysterectomy mesonephric carcinoma38
Factors that contribute to false-negative results in CT-guided transthoracic lung core-needle biopsy34
Comprehensive analysis of clinicalf eatures, treatment options, overall survival, and prognostic factors in lymphoma cell leukemia patients33
Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma31
Extent of extravasation: Patients on parenteral plant alkaloids30
Antiproliferative, apoptotic, and antimutagenic properties of stem bark and seed fractions of Polyalthia cerasoides (Roxb.)26
A rare case of miliary tuberculosis in a patient with NSCLC receiving PD1 inhibitor therapy, mimicking autoimmune pneumonitis22
The feasibility of the pretreatment verification of 2D dose distributions in radiation therapy with small fields using the electronic portal imaging device19
The Value of CEUS LI-RADS combined with AFP in early diagnosis of hepatocellular carcinoma in low- and high-risk patients19
Endometrial stromal sarcoma with sex cord differentiation19
Breast cancer in young and very young women; Is age related to outcome?19
Proton therapy for skull-base adenoid cystic carcinomas18
“Superhero” concept to avoid anesthesia for daily radiation treatment in childhood cancer16
Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop report16
Discussion on the necessity of bilateral inguinal lymphatic area irradiation for cervical cancer with invasion of the lower one-third of the vagina16
0.44702982902527